GRP
CLVS

Global Retirement Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Global Retirement Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,300
Closed -$9K – 1979
2021
Q1 		$9K Sell
1,300
-2,450
-65% -$16.4K ﹤0.01% 1339
2020
Q4 		$18K Sell
3,750
-5,125
-58% -$25.9K ﹤0.01% 1076
2020
Q3 		$52K Buy
8,875
+5,000
+129% +$29.9K 0.01% 629
2020
Q2 		$26K Hold
3,875
– – ﹤0.01% 821
2020
Q1 		$25K Hold
3,875
– – ﹤0.01% 743
2019
Q4 		$40K Sell
3,875
-1,075
-22% -$7.82K 0.01% 702
2019
Q3 		$19K Buy
4,950
+3,100
+168% +$25.1K ﹤0.01% 924
2019
Q2 		$28K Buy
1,850
+1,250
+208% +$22.6K 0.01% 783
2019
Q1 		$15K Hold
600
– – ﹤0.01% 934
2018
Q4 		$11K Buy
+600
New +$12.3K ﹤0.01% 958

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Global Retirement Partners's CLVS Position: Q2 2021 in Review

Global Retirement Partners sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 1,300 shares — an estimated $9K sold.

Global Retirement Partners first reported a position in CLVS in Q4 2018 and held it in 10 quarters. The position peaked at $52K in Q3 2020. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • Global Retirement Partners reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • Global Retirement Partners sold 1,300 Clovis Oncology, Inc. shares in Q2 2021, an estimated $9K.
  • Global Retirement Partners first reported a position in Clovis Oncology, Inc. in Q4 2018 and held it in 10 quarters.
  • Global Retirement Partners's Clovis Oncology, Inc. position peaked at $52K in Q3 2020.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Global Retirement Partners's 13F filing for Q2 2021, filed 15 Jul 2021.